In situ formation of antimicrobial silver nanoparticles and the impregnation of hydrophobic polycaprolactone matrix for antimicrobial medical device applications

被引:59
作者
Tran, Phong A. [1 ]
Hocking, Dianna M. [2 ]
O'Connor, Andrea J. [1 ]
机构
[1] Univ Melbourne, Dept Chem & Biomol Engn, Particulate Fluid Proc Ctr, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia
来源
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2015年 / 47卷
关键词
Antimicrobial; Nanoparticles; Hydrophobic polymers; Medical devices; RESPIRATORY-CHAIN; ESCHERICHIA-COLI; IONS; STAPHYLOCOCCI; BIOFILMS;
D O I
10.1016/j.msec.2014.11.016
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Bacterial infection associated with medical devices remains a challenge to modern medicine as more patients are being implanted with medical devices that provide surfaces and environment for bacteria colonization. In particular, bacteria are commonly found to adhere more preferably to hydrophobic materials and many of which are used to make medical devices. Bacteria are also becoming increasingly resistant to common antibiotic treatments as a result of misuse and abuse of antibiotics. There is an urgent need to find alternatives to antibiotics in the prevention and treatment of device-associated infections world-wide. Silver nanoparticles have emerged as a promising non-drug antimicrobial agent which has shown effectiveness against a wide range of both Gram-negative and Gram-positive pathogen. However, for silver nanoparticles to be clinically useful, they must be properly incorporated into medical device materials whose wetting properties could be detrimental to not only the incorporation of the hydrophilic Ag nanoparticles but also the release of active Ag ions. This study aimed at impregnating the hydrophobic polycaprolactone (PCL) polymer, which is a FDA-approved polymeric medical device material, with hydrophilic silver nanoparticles. Furthermore, a novel approach was employed to uniformly, incorporate silver nanoparticles into the PCL matrix in situ and to improve the release of Ag ions from the matrix so as to enhance antimicrobial efficacy. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 23 条
[11]  
2-3
[12]   Interaction of silver(I) ions with the respiratory chain of Escherichia coli:: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag [J].
Holt, KB ;
Bard, AJ .
BIOCHEMISTRY, 2005, 44 (39) :13214-13223
[13]   "Nanoantibiotics": A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era [J].
Huh, Ae Jung ;
Kwon, Young Jik .
JOURNAL OF CONTROLLED RELEASE, 2011, 156 (02) :128-145
[14]   ATTACHMENT OF STAPHYLOCOCCI TO VARIOUS SYNTHETIC-POLYMERS [J].
LUDWICKA, A ;
JANSEN, B ;
WADSTROM, T ;
PULVERER, G .
ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1984, 256 (04) :479-489
[15]  
Madhavan RV, 2011, TISSUE ENG PT A, V17, P439, DOI [10.1089/ten.tea.2009.0791, 10.1089/ten.TEA.2009.0791]
[16]   Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties [J].
Ong, Shin-Yeu ;
Wu, Jian ;
Moochhala, Shabbir M. ;
Tan, Mui-Hong ;
Lu, Jia .
BIOMATERIALS, 2008, 29 (32) :4323-4332
[17]   IN-SITU SYNTHESIS OF SILVER NANOCLUSTER IN AOT REVERSE MICELLES [J].
PETIT, C ;
LIXON, P ;
PILENI, MP .
JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (49) :12974-12983
[18]  
Scott R.D., 2009, The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention
[19]  
Song HY., 2006, Eur. Cells. Mater, V11, P58
[20]   ANTIBACTERIAL EFFECTS OF SILVER ELECTRODES WITH WEAK DIRECT-CURRENT [J].
SPADARO, JA ;
BERGER, TJ ;
BARRANCO, SD ;
CHAPIN, SE ;
BECKER, RO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (05) :637-642